Beta
SOR-2019-251:en
SOR-2019-251:en — Patent Rules
Beta. Legal information, not legal advice. LEGALDIGM is not a law firm. Check the official source for the current text.
Analyze this law with AI1 (1) The following definitions apply in these Rules.
Act means the Patent Act. (Loi)
Administrative Instructions
Administrative Instructions under the PCT means the Administrative Instructions under the Patent Cooperation Treaty, including any modifications made from time to time. (Instructions administratives du PCT)
associate patent agent means a patent agent appointed by another patent agent under section 28. (coagent)
Budapest Treaty means the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, done at Budapest on April 28, 1977, including any amendments and revisions made from time to time to which Canada is a party. (Traité de Budapest)
common representative means an applicant or patentee appointed under section 26, 218, 219 or 220. (représentant commun)
description means, except in Form 1 of Schedule 1, the part of a specification other than the claims. (description)
foreign practitioner means an individual whose name is included in the Register of Patent Agents under section 19 of the College of Patent Agents and Trademark Agents Regulations. (professionnel étranger)
international application means an application for a patent filed under the Patent Cooperation Treaty. (demande internationale)
international depositary authority has the same meaning as in Article 2(viii) of the Budapest Treaty. (autorité de dépôt internationale)
national phase entry date means the date determined under subsection 155(2) or section 210, as applicable. (date d’entrée en phase nationale)
patent agent
Patent Cooperation Treaty means the Patent Cooperation Treaty, done at Washington on June 19, 1970, including any amendments, modifications and revisions made from time to time to which Canada is a party. (Traité de coopération en matière de brevets)
PCT national phase application means an international application in respect of which the applicant
(a) has complied with the requirements of subsection 154(1) and, if applicable, subsection 154(2); or
(b) has, before October 30, 2019, complied with the requirements of subsection 58(1) and, if applicable, subsection 58(2) of the Patent Rules, as they read immediately before that date. (demande PCT à la phase nationale)
PCT sequence listing standard means Standard ST.26 of the World Intellectual Property Organization, Recommended Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings using XML (eXtensible Markup Language), as amended from time to time. (norme PCT de listages des séquences)
presentation date means the date determined under subsection 103(2) or 202(2), as applicable. (date de soumission)
Regulations under the Budapest Treaty means the Regulations under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, including any amendments made from time to time. (Règlement d’exécution du Traité de Budapest)
Regulations under the PCT means the Regulations under the Patent Cooperation Treaty, including any amendments made from time to time. (Règlement d’exécution du PCT)
sequence listing has the same meaning as in the PCT sequence listing standard. (listage des séquences)
(2) For the purposes of the Act and these Rules, drawing includes a photograph.
(3) A reference to a period of time in these Rules is, if the period is extended under section 3 or subsection 160(2) of these Rules or subsection 78(1) of the Act, to be read as a reference to the period as extended.
2 For greater certainty, for the purposes of these Rules,
(a) an application for the reissue of a patent is not considered to be an application for a patent; and
(b) a patent granted on the basis of a divisional application that results from the division of an original application is not a patent granted on the basis of the original application.
3 (1) Subject to these Rules, the Commissioner is authorized to extend any period of time fixed by these Rules for doing anything — whether that period has expired or not — if the Commissioner considers that the circumstances justify the extension and if, before the end of that period, the extension is applied for and, except in the case of the period of time fixed by subsection 86(9), the fee set out in item 1 of Schedule 2 is paid.
(2) For greater certainty, for the purpose of subsection (1), a period of time fixed by the Act that is dependent on a date that is prescribed by these Rules is not considered to be a period of time fixed by these Rules.
(3) The Commissioner is authorized to extend the period of time for the payment of a fee referred to in subsection 44(1), 68(1) or (2), 80(1), 85.1(5), 86(1), (1.1), (6), (10) or (12) or 112(1), paragraph 112(5)(a) or (c) or 154(1)(c), subsection 154(2) or subparagraph 154(3)(a)(iii) or (b)(i) or (ii) after the expiry of that period if the Commissioner considers that the circumstances justify the extension and if
(a) the amount of the small entity fee was paid before the end of that period;
(b) it is later determined that the standard fee should have been paid;
(c) the applicant or patentee files a statement that, to the best of their knowledge, the small entity fee was paid in good faith and the application for the extension is being filed without undue delay after the applicant or patentee became aware that the standard fee should have been paid;
(d) the applicant or patentee pays the difference between the amount of the small entity fee that was paid and the standard fee that was applicable on the day on which the small entity fee was paid; and
(e) the applicant or patentee pays the fee set out in item 1 of Schedule 2.
(3.1) The Commissioner is authorized to extend the period of time for the payment of a fee referred to in subsection 80(1) after the end of that period if the Commissioner considers that the circumstances justify the extension and
(a) the applicant paid an insufficient amount in a case other than one of the cases that meets the conditions set out in paragraphs (3)(a) and (b) or (4)(a) and (b) before the end of that period;
(b) the Commissioner sent a notice to the applicant acknowledging that the request for examination was made in accordance with subsection 35(2) of the Act;
(c) it was determined after the date of the notice that the payment was insufficient;
(d) the applicant files a statement declaring that the application for the extension is being filed without undue delay after the applicant became aware that the payment was insufficient and declaring that the insufficient amount was paid unintentionally; and
(e) the applicant pays the difference between the amount that was paid and the amount of the fee that was payable on the day on which the insufficient payment was made.
(4) The Commissioner is authorized to extend any period of time for the payment of a fee set out in Schedule 2 or 3 after the expiry of that period if the Commissioner considers that the circumstances justify the extension and if
(a) the Commissioner provided erroneous information in writing concerning the amount of the fee;
(b) the applicant or patentee paid an insufficient amount as a result of that erroneous information;
(c) the applicant or patentee identifies the source of the erroneous information that was relied on and files a statement that the application for the extension is being filed without undue delay after the applicant or patentee became aware that the amount paid was insufficient, unless the Commissioner considers that the circumstances do not justify requiring the statement and the application; and
(d) the applicant or patentee pays the difference between the amount that was paid and the amount of the fee that was payable on the day on which the insufficient payment was made, unless the Commissioner waives payment of the difference under section 139.1.
(5) If under any of subsections (3) to (4), the Commissioner extends the period of time for the payment of a fee, that fee is deemed to have been paid on the day on which the small entity fee was paid or the insufficient payment was made, as the case may be.
(6) Subsection (5) does not apply to the determination of the date of the payment of a fee for the purposes of subsection 128(1).
4 The Commissioner is authorized to extend the period of time fixed by subsection 18(2) of the Act — whether that period has expired or not — if the Commissioner considers that the circumstances justify the extension and if, before the end of that period, the extension is applied for and the fee set out in item 1 of Schedule 2 is paid.
5 The following days are prescribed for the purposes of subsection 78(1) of the Act:
(a) Saturday;
(b) Sunday;
(c) January 1 or, if January 1 falls on a Saturday or a Sunday, the following Monday;
(d) Good Friday;
(e) Easter Monday;
(f) the Monday before May 25;
(g) June 24 or, if June 24 falls on a Saturday or a Sunday, the following Monday;
(h) July 1 or, if July 1 falls on a Saturday or a Sunday, the following Monday;
(i) the first Monday in August;
(j) the first Monday in September;
(j.1) September 30 or, if September 30 falls on a Saturday or a Sunday, the following Monday;
(k) the second Monday in October;
(l) November 11 or, if November 11 falls on a Saturday or a Sunday, the following Monday;
(m) December 25 and 26 or
(i) if December 25 falls on a Friday, that Friday and the following Monday, and
(ii) if December 25 falls on a Saturday or a Sunday, the following Monday and Tuesday; and
(n) any day on which the Patent Office is closed to the public for all or part of the day during ordinary business hours.
5.01 If these Rules set out a small entity fee and a standard fee in respect of a patent or an application for a patent, a standard fee is deemed to be paid on the day on which a small entity fee is paid if
(a) on or before the day on which the small entity fee is paid, a small entity declaration is filed in respect of the application in accordance with subsection 44(3), or a small entity declaration is filed in accordance with subsection 112(3) in respect of the patent or in accordance with subsection 44(3) in respect of the application on the basis of which the patent was granted;
(b) it is later determined that the standard fee should have been paid;
(c) before the end of the period of time for the payment of the standard fee, the applicant or patentee pays the difference between the amount of the applicable small entity fee and the amount of the standard fee that was applicable on the day on which the small entity fee was paid; and
(d) the applicant or patentee files a statement declaring that the small entity fee was, to the best of their knowledge, paid in good faith and the difference between the amount of the applicable small entity fee and the amount of the standard fee that was applicable on the day on which the small entity fee was paid is being paid without undue delay after the applicant or patentee became aware that the standard fee should have been paid.
5.02 (1) Subject to section 5.2, if a fee is paid by means of two or more partial payments, the amount of the fee to be paid is the amount that would be payable if the full amount of the fee had been paid on the day on which the last partial payment is received.
(2) Subject to subsection (3), the amount of the fee to be paid for an examination of an application for a patent under subsection 35(1) of the Act is the amount of the fee that is payable on the day on which the request for examination is made and the fee is paid or, if the request is made and the fee is paid on different days, the later of those days.
(3) The amount of the fee to be paid for an examination of an application for a patent under subsection 35(1) of the Act is, if the applicant submits an amendment referred to in section 83.1, the amount of the fee that is payable on the day on which the applicant makes the amendment referred to in section 83.1.
5.1 Despite any provision of these Rules that sets out a small entity fee and a standard fee in respect of a patent or an application for a patent, if a patentee or applicant pays the standard fee and a small entity declaration is later filed in respect of that patent or application, the applicable fee is the standard fee.
5.2 For greater certainty, if the Commissioner extends the period of time for the payment of a fee under subsection 3(3), (3.1) or (4), the applicable fee is
(a) in the case of an extension under subsection 3(3), the standard fee that was payable on the day on which the small entity fee was paid; or
(b) in the case of an extension under subsection 3(3.1) or (4), the fee that was payable on the day on which the insufficient payment was made.
6 Written communications intended for the Commissioner or the Patent Office must be addressed to the “Commissioner of Patents”.
7 (1) A person who is doing business before the Patent Office must provide the Commissioner with their postal address and a written communication sent by the Commissioner or the Patent Office to that person at that address is, unless the communication is withdrawn, considered to have been sent to that person on the date that it bears.
(2) If a person who is doing business before the Patent Office authorizes the sending of communications by electronic means specified by the Commissioner, a written communication sent by the Commissioner or the Patent Office to that person by those means is, unless the communication is withdrawn, considered to have been sent to that person on the date borne by the communication.
8 (1) A written communication intended for the Commissioner or the Patent Office must not relate to more than one patent or one application for a patent.
(2) Subsection (1) does not apply in respect of a written communication relating to
(a) a change in a name or an address;
(b) a transfer;
(c) a request to register a document;
(d) a fee to maintain in effect an application for a patent or the rights accorded by a patent;
(e) an appointment, or revocation of an appointment, of a patent agent; or
(f) a correction of an error, if the error and correction are the same in each patent or application for a patent.
9 (1) A written communication in respect of an application for a patent that is intended for the Commissioner or the Patent Office must include the name of the applicant and the application number or, if the application number is not known, information that allows the application to be identified.
(2) A written communication in respect of a patent that is intended for the Commissioner or the Patent Office must include the name of the patentee and the patent number.
10 (1) Unless they are submitted by electronic means under subsection 8.1(1) of the Act, any documents, information or fees must be submitted to the Commissioner or the Patent Office by physical delivery to the Patent Office or to an establishment that is designated by the Commissioner as being accepted for that purpose.
(2) Documents, information or fees that are submitted to the Commissioner or the Patent Office by physical delivery to the Patent Office are deemed to have been received by the Commissioner
(a) if they are delivered when the Office is open to the public, on the day on which they are delivered; and
(b) if they are delivered when the Office is closed to the public, on the first day on which the Office is next open to the public.
(3) Documents, information or fees that are submitted to the Commissioner or the Patent Office by physical delivery to a designated establishment are deemed to have been received by the Commissioner
(a) if they are delivered when the establishment is open to the public,
(i) in the case where the Patent Office is open to the public for all or part of the day on which they are delivered, on that day, and
(ii) in any other case, on the first day on which the Patent Office is next open to the public; and
(b) if they are delivered when the establishment is closed to the public, on the first day on which the Patent Office is next open to the public that falls on or after the day on which the establishment is next open to the public.
(4) Documents, information or fees that are submitted by electronic means under subsection 8.1(1) of the Act are deemed to have been received by the Commissioner on the day on which, according to the local time of the place where the Patent Office is located, the Patent Office receives them.
(5) Despite subsection (4), if documents, information or fees referred to in that subsection are first transmitted to a service provider authorized by the Commissioner to receive them and then are either transmitted or made available to the Commissioner or the Patent Office, they are deemed to have been received by the Commissioner or the Patent Office on the day on which, according to the local time of the place where the Patent Office is located, the service provider receives them.
11 Despite sections 34 and 35, if a patent agent’s licence is suspended, revoked or surrendered, any communication respecting a patent or an application for a patent that is sent by the Commissioner or the Patent Office to that patent agent is considered not to have been sent to the patentee or applicant if
(a) it is sent within four months before the date of the suspension, revocation or surrender and no reply is provided before that date; or
(b) it is sent on the date of the suspension, revocation or surrender.
12 A written communication submitted to the Commissioner in respect of a filing under section 34.1 of the Act and a written communication submitted to the Commissioner before the granting of a patent with the stated or apparent intention of protesting against the granting of that patent must be acknowledged, but information must not be given as to the action taken unless the application for the patent is open to public inspection at the Patent Office.
13 (1) Subject to subsection (2), documents submitted in paper form in connection with a patent and an application for a patent must
(a) be submitted on sheets of white paper that are free of creases and folds and that are 21.6 cm x 27.9 cm (8.5” x 11”) or 21 cm x 29.7 cm (A4 format);
(b) be submitted in a manner that permits direct reproduction by the Patent Office; and
(c) be free of interlineations, cancellations or corrections.
(2) Certified copies of documents and documents concerning transfers referred to in section 49 of the Act may be submitted on sheets of paper that are not larger than 21.6 cm x 35.6 cm (8.5” x 14”).
14 (1) Subject to subsection (2), the contents of each page of a document must be in an upright position.
(2) If it aids in presentation, figures, tables and chemical or mathematical formulas may appear sideways.
15 (1) All documents or information submitted or made available to the Commissioner or the Patent Office must be in English or French, except for
(a) a document submitted or made available under paragraph 67(2)(b) or 72(3)(a) or subsection 74(1);
(b) the specification and the drawings included in an application for a patent on its filing date that are contained in a document referred to in paragraph 71(d);
(c) a document submitted under paragraph 85(1)(b);
(d) a copy of an international application submitted under paragraph 154(1)(a);
(e) text matter contained in a sequence listing; or
(f) a document or information that is deemed to have been received by the Commissioner under section 156.
(2) If a copy of a previously filed application for a patent is submitted or made available under paragraph 67(2)(b) and all or part of that application is in a language other than English or French, the applicant must submit to the Commissioner an English or French translation of the application or part of the application in question.
(3) If all or part of the text matter of the specification or the drawings that are contained in a document referred to in paragraph 71(d) that is submitted for the purposes of subsection 28(1) of the Act are in a language other than English or French, the applicant must submit to the Commissioner an English or French translation of that text matter.
(3.1) If a sequence listing contains text matter that is both in English and in French, only the following version of the text matter is taken into account for the purpose of interpreting the scope of protection sought or obtained:
(a) if the sequence listing contains an indication that either English or French is the original language of that text matter, the version that is in that original language; and
(b) in any other case, the version that is in the same language as the claims.
(3.2) Language-dependent free text that is contained in a sequence listing and that is in a language other than English or French is not taken into account for the purpose of interpreting the scope of protection sought or obtained.
(4) If an applicant does not submit a translation required by subsection (2) or (3), the Commissioner must by notice require the applicant to submit the translation to the Commissioner not later than two months after the date of the notice.
(5) A translation submitted under subsection (2) or (3), or submitted after the notice referred to in subsection (4) is sent, replaces the text matter that was in a language other than English or French.
(6) A translation of all or part of the text matter in a specification or a drawing, submitted under subsection (2) or (3), or submitted after the notice referred to in subsection (4) is sent, must not contain any matter not reasonably to be inferred from the specification or the drawings contained in the application on its filing date.
(7) Subsection 3(1) does not apply in respect of the time referred to in subsection (4).
16 Unless otherwise required by law, the Commissioner and the Patent Office must not provide any information in respect of an application for a patent that is not open to public inspection at the Patent Office to any person other than
(a) the applicant or, if there are joint applicants, any of the applicants;
(b) a patent agent appointed in respect of that application; or
(c) a person authorized by
(i) the applicant, if there is a single applicant,
(ii) the common representative, if there are joint applicants, or
(iii) a patent agent appointed in respect of that application.
17 For the purposes of subsection 10(4) of the Act, if a request for priority is withdrawn with respect to a previously regularly filed application for a patent, the prescribed date is the earlier of
(a) the day on which a period of 16 months after the filing date of the previously regularly filed application expires, and
(b) if the request for priority is based on more than one previously regularly filed application, the day on which a period of 16 months after the earliest of the filing dates of those applications expires.
18 For the purposes of subsection 10(5) of the Act, the prescribed date is the earlier of
(a) the day that is two months before the expiry date of the confidentiality period referred to in subsection 10(2) of the Act, and
(b) if applicable, the day on which the applicant submits their approval under subsection 10(2) of the Act for the application for a patent to be open to public inspection before the expiry of the confidentiality period.
26 (1) If, in respect of an application for a patent, there are joint applicants, one applicant may be appointed by the other applicants as their common representative.
(2) If, in respect of a patent, there are joint patentees, one patentee may be appointed by the other patentees as their common representative.
(3) The appointment of a common representative must be made by one of the following methods:
(a) in respect of a patent or an application for a patent, in a notice to that effect that is signed by the other applicants or patentees and submitted to the Commissioner;
(b) in respect of an application for a patent — other than a divisional application or an international application — that includes a petition on the filing date, in that petition; and
(c) in respect of a PCT national phase application, in a notice to that effect that is submitted to the Commissioner on or before the national phase entry date of that application.
(4) Subject to subsections (6), (9) and (11), in respect of an application for a patent — other than a divisional application — in relation to which there are joint applicants and no common representative is appointed under subsection (3), the following person is deemed to be appointed as the common representative:
(a) in respect of an application for a patent, other than a PCT national phase application,
(i) in the case where the application included a petition on the filing date, the first person named as an applicant in that petition,
(ii) in the case where, on the filing date, the application did not include a petition but did include a single other document naming the joint applicants, the joint applicant whose name appears first in that document, and
(iii) in any other case, the joint applicant whose name appears first when listed in alphabetical order on the filing date; and
(b) in respect of a PCT national phase application,
(i) if joint applicants are named in the corresponding request under Article 4 of the Patent Cooperation Treaty, if more than one applicant complied with the requirements of subsection 154(1) and, if applicable, subsection 154(2), and if the first person named as an applicant in that request is one of those applicants, the first person named as an applicant in that request, and
(ii) in any other case, the joint applicant who complied with the requirements of subsection 154(1) and, if applicable, subsection 154(2), and whose name appears first when listed in alphabetical order.
(5) Subject to subsections (6), (9) and (11), in respect of a divisional application, in relation to which there are joint applicants and no common representative is appointed under paragraph (3)(a), the following person is deemed to be appointed as the common representative:
(a) if, at the end of the day on the presentation date of the divisional application, the person who was the common representative in respect of the original application was an applicant of the divisional application, that person; and
(b) in any other case, the first person named as an applicant in the petition contained in the divisional application on its presentation date.
(6) Subject to subsections (9) and (11), in respect of an application for a patent in relation to which there are joint applicants and no common representative is appointed under subsection (3), if a correction has been made with respect to the naming of applicants under section 104 or subsection 154(6) and the correction has changed the identity of the applicants, or if a decision is made by the Commissioner under subsection 31(2), (3) or (4) of the Act, other than a decision refusing an application under one of those subsections, the joint applicant whose name appears first when listed in alphabetical order after that correction or decision — or if there is more than one correction or decision, or both a correction and a decision, after the most recent of those corrections or decisions — is deemed to be appointed as the common representative.
(7) Subject to subsections (9) and (11), in respect of a patent — other than a reissued patent — in relation to which there are joint patentees and no common representative is appointed under paragraph (3)(a), the person who, immediately before the patent was granted, was the common representative in respect of the application on the basis of which the patent was granted, is deemed to be appointed as the common representative in respect of the patent.
(8) Subject to subsections (9) and (11), in respect of a reissued patent, in relation to which there are joint patentees and no common representative is appointed under paragraph (3)(a), the person who was the common representative in respect of the original patent immediately before the patent was reissued is deemed to be appointed as the common representative in respect of the reissued patent.
(9) Subject to subsection (11), in the case where, under section 49 of the Act, the Commissioner, on or after the applicable date referred to in subsection (10), recorded the transfer of all or part of the rights of an applicant in an application for a patent or all or part of the rights of a patentee in a patent, as set out in the records of the Patent Office immediately before the transfer is recorded, that applicant was the only applicant of the application immediately before the transfer was recorded, or that patentee was the only patentee of the patent immediately before the transfer was recorded, no other person has been a single applicant of that application or a single patentee of that patent since that transfer was recorded and no common representative has been appointed under subsection (3) in respect of that application or that patent, the following person is deemed to be appointed as the common representative in respect of that patent or application:
(a) if, immediately after the transfer is recorded, the person who transferred those rights is still an applicant of the application or a patentee of the patent, that person; and
(b) if, immediately after the transfer is recorded, the person who transferred those rights is no longer an applicant of the application or a patentee of the patent, the transferee whose name appears first in the request to record the transfer.
(10) For the purposes of subsection (9), the applicable date is
(a) in respect of an application for a patent, other than a PCT national phase application or a divisional application, the filing date of the application;
(b) in respect of a PCT national phase application, the national phase entry date;
(c) in respect of a divisional application, the presentation date of the application;
(d) despite paragraphs (a) to (c), in respect of an application in relation to which one or more corrections or decisions referred to in subsection (6) have been made, the date of that correction or decision or, if there is more than one correction or decision, or both a correction and a decision, the date of the most recent of those corrections or decisions;
(e) in respect of a patent, other than a reissued patent, the date on which the patent was granted; and
(f) in respect of a reissued patent, the date on which the patent was reissued.
(11) If, under section 49 of the Act, the Commissioner records the transfer of all of the rights of a common representative in a patent or an application for a patent, as set out in the records of the Patent Office immediately before the transfer is recorded, and, immediately after the transfer is recorded, there is still more than one applicant for the patent or more than one patentee for the patent but no other common representative is appointed under paragraph (3)(a), the following person is deemed to be appointed as the common representative in respect of that patent or application:
(a) if the rights of the common representative are transferred to a single person, that person; and
(b) if the rights of the common representative are transferred to more than one person, the transferee whose name appears first in the request to record the transfer.
(12) An appointment of a common representative, including a deemed appointment, is revoked by the subsequent appointment of another common representative under paragraph (3)(a) or subsection (11).
27 (1) An applicant for a patent, a patentee or other person may appoint either one patent agent or all the patent agents at the same firm to represent them before the Patent Office in respect of a patent or an application for a patent.
(2) An applicant for a patent must appoint one patent agent or all the patent agents at the same firm to represent them before the Patent Office in respect of their application for a patent if
(a) the application is filed by a person other than the inventor;
(b) there is more than one inventor and the application is not filed jointly by all of the inventors; or
(c) a transfer, in whole or in part, of the application has been recorded by the Commissioner under section 49 of the Act.
(3) The appointment of one patent agent or all the patent agents at the same firm by an applicant for a patent or a patentee must be made by one of the following methods:
(a) in respect of a patent or an application for a patent, in a notice to that effect that is submitted to the Commissioner and signed by
(i) if there is a single applicant or patentee, the applicant or patentee,
(ii) if there is a single applicant or patentee and a document authorizing a foreign practitioner to appoint a patent agent is signed by the applicant or patentee and submitted at the same time to the Commissioner, that foreign practitioner,
(iii) if there are joint applicants or patentees, the common representative, or
(iv) if there are joint applicants or patentees and a document authorizing a foreign practitioner to appoint a patent agent is signed by the common representative and submitted at the same time to the Commissioner, that foreign practitioner;
(b) in respect of an application for a patent — other than a divisional application or an international application — that includes a petition on the filing date, in that petition;
(c) in respect of a PCT national phase application, in a notice to that effect submitted to the Commissioner on or before the national phase entry date of that application; and
(d) in respect of a divisional application, in the petition included in the application on its presentation date.
(4) The appointment, other than as an associate patent agent, of one patent agent or all the patent agents at the same firm, by a person other than an applicant for a patent or a patentee to represent them before the Patent Office in respect of a patent or an application for a patent must be made in a notice to that effect submitted to the Commissioner and signed by
(a) that person; or
(b) if a document signed by that person authorizing a foreign practitioner to appoint a patent agent is submitted at the same time to the Commissioner, that foreign practitioner.
(5) If a person, other than a patent agent, submits to the Commissioner a document appointing, other than as an associate patent agent, one patent agent or all the patent agents at the same firm, the appointment is not effective until evidence of consent to that appointment by that one patent agent or by any of the patent agents at that firm is submitted to the Commissioner.
(6) The patent agent or all the patent agents at the same firm appointed in respect of an application for a patent under subsection 27(3) or (4) are deemed, unless the appointment document indicates otherwise, to have also been appointed in respect of any patent granted on the basis of the application.
(7) The appointment, including a deemed appointment, of one patent agent or all the patent agents at the same firm in respect of a patent or an application for a patent by an applicant for a patent or a patentee is revoked if
(a) a notice to that effect is submitted to the Commissioner and signed by that one patent agent or any of the patent agents at that firm or by
(i) if there is a single applicant or patentee, the applicant or patentee,
(ii) if there is a single applicant or patentee and a document authorizing a foreign practitioner to revoke the appointment is signed by the applicant or patentee and is submitted at the same time to the Commissioner, that foreign practitioner,
(iii) if there are joint applicants or patentees, the common representative, or
(iv) if there are joint applicants or patentees and a document signed by the common representative authorizing a foreign practitioner to revoke the appointment is submitted at the same time to the Commissioner, that foreign practitioner; or
(b) the licence of that one patent agent, or each of the patent agents at that firm, is suspended, revoked or surrendered.
(8) The appointment, including a deemed appointment, other than as an associate patent agent, of one patent agent or all the patent agents at the same firm, in respect of a patent or an application for a patent by a person other than an applicant for a patent or a patentee is revoked if
(a) a notice to that effect, signed by that person, by that one patent agent or by any of the patent agents at that firm, is submitted to the Commissioner;
(b) a document signed by that person authorizing a foreign practitioner to revoke the appointment is submitted to the Commissioner at the same time as a notice revoking the appointment signed by that foreign practitioner; or
(c) the licence of that one patent agent, or each of the patent agents at that firm, is suspended, revoked or surrendered.
28 (1) A patent agent appointed by an applicant for a patent, a patentee or other person to represent them before the Patent Office in respect of a patent or an application for a patent may appoint one patent agent or all the patent agents at the same firm as an associate patent agent in respect of that patent or application.
(2)
(3) The appointment of one patent agent or all the patent agents at the same firm as an associate patent agent must be made by one of the following methods:
(a) in respect of a patent or an application for a patent, in a notice to that effect that is signed by the patent agent appointing the associate patent agent and submitted to the Commissioner;
(b) in respect of an application for a patent — other than a divisional application or an international application — that includes a petition on the filing date, in that petition if the petition is submitted by a patent agent;
(c) in respect of a PCT national phase application, in a notice to that effect submitted to the Commissioner by a patent agent on or before the national phase entry date of that application; and
(d) in respect of a divisional application, in the petition included in the application on its presentation date if the petition is submitted by a patent agent.
(4) Any associate patent agent appointed in respect of an application for a patent under subsection (3) is deemed, unless the appointment document indicates otherwise, to have also been appointed in respect of any patent granted on the basis of the application.
(5) The appointment, including a deemed appointment, of one patent agent as an associate patent agent in respect of a patent or an application for a patent is revoked if
(a) in the case where the associate patent agent was appointed by one patent agent who was appointed under subsection 27(3) or (4),
(i) a notice of revocation signed by the associate patent agent or the patent agent is submitted to the Commissioner,
(ii) the associate patent agent’s licence is suspended, revoked or surrendered, or
(iii) the appointment of the patent agent is revoked; and
(b) in the case where the associate patent agent was appointed by one of the patent agents at the same firm who were appointed under subsection 27(3) or (4),
(i) a notice of revocation signed by the associate patent agent or by one of the patent agents at the firm is submitted to the Commissioner,
(ii) the associate patent agent’s licence is suspended, revoked or surrendered, or
(iii) the appointment of all the patent agents at the firm is revoked.
(5.1) The appointment, including a deemed appointment, as an associate patent agent, of all the patent agents at the same firm in respect of a patent or an application for a patent is revoked if
(a) in the case where they were appointed by one patent agent who was appointed under subsection 27(3) or (4),
(i) a notice of revocation signed by one of the patent agents at the firm acting as an associate patent agent or by the patent agent who appointed them is submitted to the Commissioner,
(ii) the licence of each of the patent agents acting as an associate patent agent is suspended, revoked or surrendered, or
(iii) the appointment of the patent agent is revoked; and
(b) in the case where they were appointed by one of the patent agents at the same firm who were appointed under subsection 27(3) or (4),
(i) a notice of revocation signed by one of the patent agents at the firm acting as an associate patent agent, or by one of the patent agents at the firm that appointed them, is submitted to the Commissioner,
(ii) the licence of each of the patent agents acting as an associate patent agent is suspended, revoked or surrendered, or
(iii) the appointment under subsection 27(3) or (4) of all the patent agents at the firm is revoked.
28.1 If all the patent agents at the same firm have been appointed under section 27 or 28, the following rules apply:
(a) a patent agent who becomes a member of the firm after the appointment is deemed to be appointed beginning on the day on which they become a member of the firm;
(b) a person who is a member of the firm who becomes a patent agent after the appointment is deemed to have been appointed beginning on the day on which they become a patent agent;
(c) the appointment of a patent agent who ceases to be a member of the firm is deemed to be revoked on the day on which they cease to be a member of the firm; and
(d) the appointment of a patent agent whose licence is suspended, revoked or surrendered is deemed to be revoked on the day on which their licence is suspended, revoked or surrendered.
29 (1) A document appointing one patent agent must include the name and postal address of that patent agent.
(2) A document appointing all the patent agents at the same firm must include the name and postal address of the firm. An appointment document that includes only the name and postal address of the firm is sufficient to appoint all the patent agents at that firm.
29.1 If all the patent agents at the same firm have been appointed or are deemed to have been appointed under section 27 or 28, any written communication sent by the Commissioner or the Patent Office to the firm is considered to have been sent to all of the patent agents at the firm.
30 The patent agent or all the patent agents at the same firm who were appointed, other than as an associate patent agent, to represent an applicant or patentee before the Patent Office are, unless otherwise indicated in a request to record a transfer under subsection 49(2) or (3) of the Act, deemed to have been appointed by the transferee in respect of the patent or the application that is the subject of the recording.
31 If an applicant for a patent is required under subsection 27(2) to appoint a patent agent but no patent agent is appointed, the Commissioner must by notice to the applicant require that, not later than three months after the date of the notice, the applicant appoint a patent agent.
32 (1) A patent agent who, in respect of a patent or application for a patent, demonstrates to the Commissioner that they are the successor to a patent agent or all the patent agents at the same firm who were appointed under section 27 or 28 and who have since withdrawn from practice is deemed to be appointed under section 27 or 28, as the case may be, in respect of that patent or application.
(2) All the patent agents at the same firm who, in respect of a patent or application for a patent, demonstrate to the Commissioner that they are the successors to a patent agent or all the patent agents at the same firm who were appointed under section 27 or 28 and who have since withdrawn from practice are deemed to be appointed under section 27 or 28, as the case may be, in respect of that patent or application.
33 Subject to sections 36 and 37, in any business before the Patent Office, an act done in respect of a patent or an application for a patent, by or in relation to a common representative, has the effect of an act done by or in relation to all of the applicants or patentees.
34 Subject to sections 36 and 37, in any business before the Patent Office, an act done in respect of a patent or an application for a patent, by or in relation to a patent agent, other than an associate patent agent, who is appointed in respect of that application or patent, has the same effect as an act done by or in relation to the applicant for a patent, a patentee or other person who appointed the patent agent.
35 Subject to sections 36 and 37, in any business before the Patent Office, an act done in respect of a patent or an application for a patent, by or in relation to an associate patent agent appointed in respect of that application or patent, has the same effect as an act done by or in relation to the applicant for a patent, a patentee or other person who appointed the patent agent who appointed the associate patent agent.
36 (1) Subject to subsections (2) to (5), only the following persons are authorized to act in any business before the Patent Office for the purpose of prosecuting or maintaining in effect an application for a patent:
(a) if, in respect of the application, a patent agent is appointed or there is a requirement under subsection 27(2) to appoint a patent agent, the patent agent who is appointed; and
(b) in any other case,
(i) if there is a single applicant, the applicant, and
(ii) if there are joint applicants, the common representative.
(2) For the purposes of filing an application for a patent, paying a fee under subsection 27(2) or section 27.1 of the Act, paying the additional fee for late payment referred to in subsection 154(4) of these Rules or complying with the requirements of subsection 154(1), (2) or (3) of these Rules,
(a) if there is a single applicant, they must represent themselves or be represented by a person authorized by the applicant; and
(b) if there are joint applicants, they must be represented by one of the applicants or by a person authorized by one of the applicants.
(3) For the purpose of submitting a request to record a transfer under subsection 49(2) of the Act,
(a) if there is a single applicant, they must represent themselves or be represented by a person authorized by the applicant; and
(b) if there are joint applicants,
(i) in the case where the transfer is a transfer of the right or interest of a single joint applicant, the joint applicants must be represented by that joint applicant or by the common representative, or by a person authorized by that joint applicant or by the common representative, and
(ii) in any other case, the joint applicants must be represented by the common representative or by a person authorized by the common representative.
(4) For the purposes of submitting a request to record a name change under section 125,
(a) if there is a single applicant, they must represent themselves or be represented by a person authorized by the applicant; and
(b) if there are joint applicants, they must be represented by the common representative or by a person authorized by the common representative.
(5) For the purposes of section 27.01 or 28.01 of the Act, for the purpose of paying a fee in respect of an application for a patent — other than a fee under subsection 27(2) or section 27.1 of the Act or a fee referred to in subsection 154(1), (2), (3) or (4) of these Rules — or for the purpose of taking any of the actions required by subparagraphs 73(3)(a)(i) to (iv) of the Act to reinstate an application for a patent deemed to be abandoned under paragraph 73(1)(c) of the Act,
(a) if there is a single applicant, they may represent themselves; and
(b) if there are joint applicants, they may be represented by the common representative.
37 (1) Subject to subsection (2), in any business before the Patent Office for the purpose of a procedure relating to a patent,
(a) if there is a single patentee, they must represent themselves or be represented by any person authorized by them; and
(b) if there are joint patentees,
(i) for the purpose of paying a fee under section 46 of the Act, the patentees must be represented by one of the patentees or by a person authorized by one of the patentees,
(ii) for the purpose of submitting a request to record a transfer under subsection 49(3) of the Act,
(A) in the case where the transfer is a transfer of the right or interest of a single joint patentee, the joint patentees must be represented by that joint patentee or by the common representative, or by a person authorized by that joint patentee or by the common representative, and
(B) in any other case, the joint patentees must be represented by the common representative or a person authorized by the common representative, and
(iii) for any other purpose, the patentees must be represented by the common representative or by a person authorized by the common representative.
(2) In any business before the Patent Office for the purposes of making observations under subsection 117.11(7), granting an additional term under section 46.1 of the Act, reissuing a patent under section 47 of the Act, making a disclaimer under section 48 of the Act, filing a reply under subsection 48.2(5) of the Act or participating in a re-examination proceeding under section 48.3 of the Act,
(a) if there is a single patentee, they must represent themselves or be represented by a patent agent who has been appointed in respect of that business; and
(b) if there are joint patentees, the patentees must be represented by the common representative or by a patent agent who has been appointed in respect of that business.
38 For greater certainty, sections 33 to 37 do not apply to the act of signing
(a) a small entity declaration;
(b) a notice of appointment of a common representative or a patent agent;
(c) a notice of revocation of an appointment of a patent agent; or
(d) a document authorizing a foreign practitioner to appoint or revoke the appointment of a patent agent, have an interview with an examiner or sign a small entity declaration.
39 Only the following persons may have an interview with an examiner regarding an application for a patent:
(a) if, in respect of that application, a patent agent is appointed or there is a requirement under subsection 27(2) to appoint a patent agent,
(i) the patent agent who is appointed, and
(ii) with the permission of the patent agent who is appointed,
(A) if there is a single applicant, the applicant,
(B) if there is a single applicant and a document authorizing a foreign practitioner to have an interview with an examiner is signed by the applicant, that foreign practitioner,
(C) if there are joint applicants, the common representative, or
(D) if there are joint applicants and a document authorizing a foreign practitioner to have an interview with an examiner is signed by the common representative, that foreign practitioner; and
(b) in any other case,
(i) the applicant, if there is a single applicant, and
(ii) the common representative, if there are joint applicants.
40 (1) If, in any business for the purpose of prosecuting or maintaining in effect an application for a patent or for the purpose of a procedure relating to a patent, a joint applicant or joint patentee who is not the common representative of the joint applicants or joint patentees sends a written communication to the Commissioner in respect of any business for which the common representative is entitled to represent the applicants or the patentees, the Commissioner must by notice inform that joint applicant or joint patentee that the Commissioner will not have regard to that communication unless, not later than three months after the date of the notice, that joint applicant or joint patentee is appointed in accordance with paragraph 26(3)(a) to represent the applicants or patentees as the common representative and requests that the Commissioner have regard to the communication.
(1.1) The notice referred to in subsection (1) must also be sent to the common representative of the joint applicants or joint patentees.
(2) Subsection (1) does not apply to a communication in respect of any business under subsection 36(2), (3) or (4) or to a communication in respect of any business for the purpose of a procedure relating to a patent, other than a communication in respect of business referred to in subsection 37(2).
(3) If, not later than three months after the date of the notice referred to in subsection (1), the joint applicant or joint patentee who sent a written communication to the Commissioner is appointed under paragraph 26(3)(a) to represent the applicants or patentees as their common representative and requests that the Commissioner have regard to the communication, the communication is deemed to have been received from the common representative on the date on which it was originally received from the joint applicant or joint patentee.
41 (1) If a patent agent who is not appointed to represent an applicant or patentee in respect of a patent or an application for a patent communicates in writing with the Commissioner on behalf of that applicant or patentee for the purpose of prosecuting or maintaining in effect that application or for the purpose of a procedure relating to that patent and the communication identifies that patent agent, the Commissioner must by notice inform the patent agent that the Commissioner will not have regard to that communication unless, not later than three months after the date of the notice, the patent agent is appointed to represent that applicant or patentee in respect of that application or patent and requests that the Commissioner have regard to the communication.
(1.1) The notice must also be sent to the applicant or to the patentee.
(2) Subsection (1) does not apply to a communication in respect of any business under subsection 36(2), (3) or (4) or to a communication in respect of any business for the purpose of a procedure relating to a patent, other than a communication in respect of any business referred to in subsection 37(2).
(3) If, not later than three months after the date of the notice referred to in subsection (1), the patent agent is appointed to represent that applicant or patentee in respect of that patent or application for a patent and requests that the Commissioner have regard to the communication, the communication is deemed to have been received from the applicant or patentee on the date on which the communication was originally received from the patent agent.
41.1 (1) In any business before the Patent Office in respect of which a patent agent acts under subsection 36(1) or (5), or represents a patentee under subsection 37(2), written communications on behalf of the applicant or patentee must be submitted to the Commissioner or the Patent Office by a named patent agent.
(2) If the patent agent is not named, the Commissioner must by notice inform the sender that the Commissioner will not have regard to the communication unless, not later than three months after the date of the notice, the patent agent who submitted the communication provides their name to the Commissioner and requests that the Commissioner have regard to the communication.
(2.1) The notice must also be sent to the applicant or the patentee.
(3) If the name of the patent agent and the request referred to in subsection (2) are provided to the Commissioner within the time limit set out in that subsection, the original communication is considered to have been received on the day on which it was actually received by the Commissioner or the Patent Office.
42 If the Governor in Council orders, under subsection 20(17) of the Act, that an invention described in an application for a patent must be treated for the purposes of section 20 of the Act as if it had been assigned or agreed to be assigned to the Minister of National Defence, the Commissioner must, as soon as the Commissioner is informed of the order, notify the applicant.
43 The Commissioner must permit a public servant who is authorized in writing by the Minister of National Defence, or an officer of the Canadian Forces who is authorized in writing by the Minister of National Defence, to inspect a pending application for a patent that relates to an instrument or munition of war to do so and to obtain a copy of the application.
44 (1) For the purposes of subsection 27(2) of the Act, the prescribed application fee is
(a) the small entity fee set out in item 6 of Schedule 2, if the small entity status condition set out in subsection (2) is met and a small entity declaration is filed in respect of the application for a patent in accordance with subsection (3),
(i) on or before the filing date of the application or, in the case of a divisional application, on or before the presentation date of the divisional application, or
(ii) if a notice is required to be given under subsection 27(7) of the Act, before the notice is given or, if the notice has been given, not later than three months after the date of the notice; and
(b) in any other case, the standard fee set out in that item.
(2) The small entity status condition is that
(a) in respect of an application for a patent — other than a PCT national phase application or a divisional application — the applicant of the application on the filing date is, on that date, an entity that has fewer than 100 employees or is a university, other than
(i) an entity that is controlled directly or indirectly by an entity, other than a university, that has 100 employees or more, or
(ii) an entity that has transferred or licensed, or has an obligation other than a contingent obligation to transfer or license, any right or interest in a claimed invention to an entity, other than a university, that has 100 employees or more;
(b) in respect of an international application, the applicant of the application on the national phase entry date is, on that date, an entity that has fewer than 100 employees or is a university, other than an entity referred to in subparagraph (a)(i) or (ii); and
(c) in respect of a divisional application, the applicable requirements of this subsection are met in respect of the original application.
(3) A small entity declaration must
(a) be filed with the Commissioner in the petition or in a document other than the abstract, the specification or the drawings, that identifies the application for a patent to which the declaration relates;
(b) contain a statement to the effect that the applicant believes that the small entity status condition set out in subsection (2) is met in respect of that application for a patent;
(c) be signed by a patent agent appointed in respect of that application or
(i) if there is a single applicant, the applicant,
(ii) if there is a single applicant and a document authorizing a foreign practitioner to sign a small entity declaration is signed by the applicant and submitted to the Commissioner at the same time as the declaration, that foreign practitioner,
(iii) if there are joint applicants, any one of the applicants, or
(iv) if there are joint applicants and a document authorizing a foreign practitioner to sign a small entity declaration is signed by any one of the applicants and submitted to the Commissioner at the same time as the declaration, that foreign practitioner; and
(d) indicate the name of the applicant and, if applicable, the name of the patent agent or the foreign practitioner signing the declaration.
(4) Subsection 3(1) does not apply in respect of the times referred to in subsection (1).
45 For the purposes of subsection 27(7) of the Act, the prescribed late fee is the fee set out in item 7 of Schedule 2.
46 The text matter in the abstract, the description, the drawings and the claims, other than any text matter contained in a sequence listing, must be entirely in English or entirely in French.
47 (1) The minimum margins of pages that contain the description, the claims or the abstract must be as follows:
top margin, 2 cm
left margin, 2.5 cm
right margin, 2 cm
bottom margin, 2 cm
(2) The minimum margins of pages containing the drawings must be as follows:
top margin, 2.5 cm
left margin, 2.5 cm
ri
The text continues in the official source.
